Literature DB >> 25043518

Should DWI MRI be the primary screening test for stroke?

Ronen R Leker1, Galina Keigler, Roni Eichel, Tamir Ben Hur, John M Gomori, Jose E Cohen.   

Abstract

Patients presenting with focal neurological symptoms may suffer from ischemic stroke, intracerebral hemorrhage, or stroke mimics. Such patients are usually screened with a noncontrast-enhanced computed tomography to rule out hemorrhage and to detect early signs of ischemia. However, the sensitivity of noncontrast-enhanced computed tomography for acute stroke is far inferior to that of diffusion-weighted magnetic resonance imaging and the latter is also very sensitive for identifying acute intracerebral hemorrhage. Most centers perform a magnetic resonance imaging stroke protocol that takes long to accomplish and may therefore delay therapy. Herein, we propose that a short diffusion-weighted imaging-only magnetic resonance imaging protocol can effectively differentiate ischemic stroke from intracerebral hemorrhage and stroke mimics and could therefore be used as the first line screening test for stroke. Adopting such a screening strategy will result in increased diagnostic accuracy and avoidance of unnecessary treatment of stroke mimics with thrombolysis but may come at the increased cost of performing a magnetic resonance imaging at the emergency department. Whether such a strategy will be cost effective or not remains to be tested in future studies.
© 2014 World Stroke Organization.

Entities:  

Keywords:  CT; diffusion-weighted MRI; stroke; stroke mimics; thrombolysis

Mesh:

Year:  2014        PMID: 25043518     DOI: 10.1111/ijs.12316

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  2 in total

1.  Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.

Authors:  Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia
Journal:  Neurology       Date:  2015-05-13       Impact factor: 9.910

2.  Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic.

Authors:  Manu S Goyal; Brian G Hoff; Jennifer Williams; Naim Khoury; Rebecca Wiesehan; Laura Heitsch; Peter Panagos; Katie D Vo; Tammie Benzinger; Colin P Derdeyn; Jin-Moo Lee; Andria L Ford
Journal:  Stroke       Date:  2016-02-18       Impact factor: 7.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.